đź“Ť Brooklyn, New York City – 🗓️ July 8, 2025
✍️ By PharmaDigital.AI Team
Today, our CEO Bartosz HoĹ‚yĹ„ski had the opportunity to attend DigiMarCon East 2025 in Brooklyn – a premier digital marketing conference showcasing the most impactful trends shaping our industry. While the event wasn’t tailored specifically to the pharmaceutical sector, it delivered cutting-edge insights that we’re already translating into actionable strategies for regulated industries like healthcare and pharmacy.
🔍 Why Events Like DigiMarCon Matter – Even for Pharma
The digital marketing space is evolving faster than ever, largely driven by AI, data integration, and channel diversification. Events like DigiMarCon gather some of the best minds in the business to explore these shifts in real time.
For a highly regulated sector like pharma, staying ahead of these changes isn’t optional – it’s mission-critical.
🤖 AI Marketing – From Hype to Strategic Application
A recurring theme of the day was the transformative power of AI in marketing – from automating content generation and campaign deployment to analyzing customer intent in real time.
Our team took away several AI applications that are directly relevant to the pharma world, including
- Smarter segmentation of HCPs and patients
- Predictive content suggestions tailored to compliance requirements
- Conversational AI for patient education and support channels
- AI-assisted KPI tracking and optimization
While many marketers are still in the “testing” phase, our deep domain knowledge allows us to adapt these tools for pharma realities – safely and effectively.
⚙️ AI Automations & Workflow Agents
A standout discussion explored the rise of AI agents – autonomous systems that execute specific marketing tasks across workflows.
We’re especially excited about applying this concept in pharma to streamline
- Consent-driven communication flows
- Localized campaign deployment based on pharmacy performance
- Dynamic content testing for different audience personas
Imagine deploying a campaign to GPs in London and pharmacists in KrakĂłw – and letting AI coordinate the tone, timing, and regulatory compliance autonomously. This is the future we’re building toward.
📡 Offline Targeting – Bridging the Physical and Digital
One of the more insightful sessions came from Bruce from USADATA, who shared how to turn offline consumer data – store visits, demographic clusters, behavioral signals – into precise online targeting.
We’re pleased to announce that after productive conversations, we’ll soon begin collaborating with USADATA. This partnership will allow us to map real-world pharmacy behaviors onto digital campaigns, targeting patients where it matters most – both physically and digitally.
In pharma, where offline activity is still a major source of patient decision-making, this capability is a game-changer.
đź’˝ First-Party Data – The Foundation of Ethical Targeting
As the industry moves away from third-party cookies, first-party data has become essential. Multiple sessions at DigiMarCon explored how brands are
- Building consent-driven data ecosystems
- Leveraging CRM and loyalty systems
- Creating personalized, privacy-first experiences
This aligns with our long-standing commitment to ethical, compliant targeting. The insights from today’s sessions only strengthened our conviction – and gave us new tools to support our clients in doing the same.
đź“Ł Omnichannel Isn’t Optional Anymore
Whether through email, social, in-app messaging, or even in-pharmacy digital displays – today’s sessions highlighted that brands must now be everywhere their audience is.
Pharma is no exception. If your campaign lives only on one channel, you’re missing 70% of the conversation. We’re taking the latest channel orchestration strategies back to our pharma clients, helping them unify messaging across digital and offline environments – without losing regulatory control.
🧠From Inspiration to Execution
DigiMarCon East was more than a showcase of tools – it was a blueprint for what modern marketing can and should look like. And while the sessions were built for broad industries, our team’s unique expertise means we know exactly how to translate those innovations into the language of pharmaceutical marketing.
From AI-powered campaign engines to offline-informed media buying, we’re ready to apply what we’ve learned – not in six months, but now.
🚀 Next Steps
As we integrate these insights into our strategies and systems, we’ll continue to share updates with our clients and community. The future of pharma marketing doesn’t have to lag behind digital – it can lead, if done responsibly.
đź’¬ Want to learn how we’re bringing AI, automation, and omnichannel precision into the pharma space – Let’s talk.